• 四川大學(xué)華西醫(yī)院循證醫(yī)學(xué)與臨床流行病學(xué)教研室(成都 610041);

目的  在循證臨床實踐中,醫(yī)務(wù)人員需要正確理解臨床研究中療效指標(biāo)的意義。本研究旨在評價相同臨床研究結(jié)果的不同表述方式對研究生選擇和推薦治療措施的影響,從而了解已經(jīng)過“臨床科研設(shè)計”課程學(xué)習(xí)的研究生對療效指標(biāo)的理解。
方法  將同一系統(tǒng)評價的結(jié)果采用4種療效指標(biāo)表述,設(shè)計問卷對參與“臨床科研設(shè)計”課程考試的研究生進行調(diào)查。
結(jié)果  共發(fā)出和收回問卷342份,排除4份未回答所有結(jié)果的問卷,有效問卷338份。結(jié)果顯示,研究生選擇絕對危險度降低率(ARR)與需要治療的患者數(shù)(NNT)、相對危險度降低率(RRR)與NNT、試驗組和對照組未發(fā)生事件率的差異(EFP)與NNT間的分值差異和治療推薦級別差異均有統(tǒng)計學(xué)意義(P lt;0.01);ARR、RRR與EFP間差異無統(tǒng)計學(xué)意義。但279名研究生選擇4種療效指標(biāo)得分的極差大于4分。
結(jié)論  經(jīng)過“臨床科研設(shè)計”課程學(xué)習(xí)的研究生在理解療效指標(biāo)意義上仍然存在問題。因此,課堂教學(xué)應(yīng)加強對臨床研究結(jié)果的不同表述方式和相關(guān)指標(biāo)臨床意義的講解。

引用本文: 李靜,艾昌林,張鳴明,袁文明,徐琳,張小利,劉關(guān)鍵,李幼平. 研究結(jié)果的表述方式是否會影響治療決策. 中國循證醫(yī)學(xué)雜志, 2007, 07(5): 344-347. doi: 復(fù)制

1. Nexoe J, Gyrd-Hansen D, Kragstrup J, et al. Danish GPs’ perception of disease risk and benefit of prevention. Fam Pract, 2002, 19(1): 3-6.
2. Fahey T, Griffiths S, Peters TJ. Evidence based purchasing: understanding results of clinical trials and systematic reviews. BMJ, 1995, 311(7012): 1056-1059; discussion 1059-1060.
3. Oldridge NB, Guyatt GH, Fischer ME, et al. Cardiac rehabilitation after myocardial infarction. Combined experience of randomized clinical trials. JAMA, 1988, 260(7): 945-950.
4. Barratt A, Wyer PC, Hatala R, et al. Tips for learners of evidence-based medicine: 1. Relative risk reduction, absolute risk reduction and number needed to treat. CMAJ, 2004, 171(4): 353-358.
5. Cranney M, Walley T. Same information, different decisions: the influence of evidence on the management of hypertension in the elderly. Br J Gen Pract, 1996, 46(412): 661-663.
6. Nexoe J, Oltarzewska AM, Sawicka-Powierza J, et al. Perception of risk information. Similarities and differences between Danish and Polish general practitioners. Scand J Prim Health Care, 2002, 20(3): 183-187.
  1. 1. Nexoe J, Gyrd-Hansen D, Kragstrup J, et al. Danish GPs’ perception of disease risk and benefit of prevention. Fam Pract, 2002, 19(1): 3-6.
  2. 2. Fahey T, Griffiths S, Peters TJ. Evidence based purchasing: understanding results of clinical trials and systematic reviews. BMJ, 1995, 311(7012): 1056-1059; discussion 1059-1060.
  3. 3. Oldridge NB, Guyatt GH, Fischer ME, et al. Cardiac rehabilitation after myocardial infarction. Combined experience of randomized clinical trials. JAMA, 1988, 260(7): 945-950.
  4. 4. Barratt A, Wyer PC, Hatala R, et al. Tips for learners of evidence-based medicine: 1. Relative risk reduction, absolute risk reduction and number needed to treat. CMAJ, 2004, 171(4): 353-358.
  5. 5. Cranney M, Walley T. Same information, different decisions: the influence of evidence on the management of hypertension in the elderly. Br J Gen Pract, 1996, 46(412): 661-663.
  6. 6. Nexoe J, Oltarzewska AM, Sawicka-Powierza J, et al. Perception of risk information. Similarities and differences between Danish and Polish general practitioners. Scand J Prim Health Care, 2002, 20(3): 183-187.